Understanding CAN CSA C22.2 No. 60601-2-29-10 (2018): Safety and Performance Requirements for Radiotherapy Simulators in Canada

A technical overview of the Canadian adoption of IEC 60601-2-29 governing medical electrical equipment for radiotherapy simulation

Introduction

CAN CSA C22.2 No. 60601-2-29-10 (2018) is a Canadian national standard that adopts the international IEC 60601-2-29:2015 with specific Canadian deviations. It belongs to the C22.2 series of standards for medical electrical equipment and addresses the basic safety and essential performance requirements for radiotherapy simulators — devices used to simulate radiation treatment fields prior to actual therapy delivery. Compliance with this standard is mandatory for manufacturers seeking Health Canada licensure under the Medical Devices Regulations (SOR/98-282).

Scope

The standard applies to:

  • Radiotherapy simulators used in radiation oncology to define treatment volumes, localize critical structures, and generate verification images
  • Equipment that uses X-ray imaging (e.g., computed tomography, conventional radiography) while the therapy couch and gantry positions replicate those of a linear accelerator
  • Systems intended for use by qualified healthcare professionals in a clinical environment

Excluded from scope are simulation-specific components integrated into treatment devices (e.g., cone-beam CT on a linear accelerator) unless declared as a radiotherapy simulator by the manufacturer.

Important: CAN CSA C22.2 No. 60601-2-29-10 (2018) supersedes earlier editions and must be used in conjunction with the general standard CAN CSA C22.2 No. 60601-1 (Ed. 3 or later) and the collateral standards applicable to radiological equipment (e.g., CAN CSA C22.2 No. 60601-1-2 for EMC).

Technical Requirements

The standard establishes detailed requirements in several key areas. A summary of principal technical provisions is provided in the table below.

Requirement Area Key Provisions Reference Clause
Essential Performance Accuracy of field definition (light field vs. radiation field congruence ≤ 2mm), couch indexing precision ±1mm, gantry angle indication error ≤ 0.5° Clause 201.12
Radiation Protection Leakage radiation from the simulator head ≤ 0.1% of useful beam in patient plane; protective shielding for operator and public Clause 203.2
Electrical Safety Compliance with CAN CSA C22.2 No. 60601-1: patient leakage current limits (e.g., 10 µA under normal condition, 50 µA under single fault) Clause 201.6
Electromagnetic Compatibility Emissions per CISPR 11; immunity levels for radiated RF fields (3 V/m for professional healthcare environment) Clause 202
Software and Imaging DICOM conformance for image exchange; validation of image quality parameters (spatial resolution, low-contrast detectability) Clause 204.4
Mechanical Safety Anti-collision mechanisms, emergency stops at control panel and on gantry, stability under tilt (10°) Clause 205.1

Specific Canadian Modifications

The CSA version includes deviations from IEC 60601-2-29:2015, notably:

  • Bilingual labeling — All warning labels and user documentation must be in English and French.
  • Measurement units — Use of SI units (Gy, mSv) throughout.
  • Climatic conditions — Updated ambient temperature/humidity ranges to suit Canadian healthcare facilities.
  • Reference standards — Substitution of certain ASTM/ISO references with equivalent CSA standards where applicable.

Implementation Highlights

Manufacturers integrating the requirements of CAN CSA C22.2 No. 60601-2-29-10 should consider the following implementation strategies:

  • Risk management file: Update the risk analysis to include specific hazards of radiotherapy simulation (e.g., incorrect isocenter positioning, collision during imaging). The standard requires the risk management process to conform to ISO 14971.
  • Essential performance verification: Design test procedures to validate field congruence and couch positioning accuracy under simulated clinical loading.
  • EMC testing: Plan for radiated immunity testing at 3 V/m from 80 MHz to 2.5 GHz; consider higher levels for life-supporting functions not applicable here, but ensure simulator does not degrade below essential performance.
  • Software lifecycle: If the simulator uses software for image reconstruction or control, apply IEC 62304 for a Class B or C device (depending on risk). The standard preserves these requirements.
Tip: Early engagement with a recognized certification body (e.g., CSA Group, UL, Intertek) can streamline the review of the technical file, especially for the Canadian deviations. Expect at least 12–18 months for full certification if starting from scratch.

Compliance and Certification Notes

To achieve certification to CAN CSA C22.2 No. 60601-2-29-10 (2018), manufacturers must:

  1. Compile a technical documentation package per Health Canada guidance (CMDCAS or MDSAP audit).
  2. Demonstrate conformity with applicable parts of the IEC 60601-1 series, including CAN CSA C22.2 No. 60601-1 (Ed. 3) and 60601-1-2, 60601-1-6 (usability), 60601-1-8 (alarms), and 60601-2-29.
  3. Provide evidence of testing performed by an ISO 17025 accredited laboratory or a recognized certification body.
  4. Include a declaration of conformity and a list of essential performance characteristics identified during risk management.
Warning: Non-compliance with CAN CSA C22.2 No. 60601-2-29-10 may result in denial of Health Canada medical device licence or recall orders. Devices that fail to meet essential performance criteria (especially dose accuracy) pose significant patient safety risks and are subject to mandatory reporting under the Medical Devices Regulations.

Frequently Asked Questions

Q: How does CAN CSA C22.2 No. 60601-2-29-10 differ from the international IEC 60601-2-29:2015?
A: The CSA edition includes Canadian-specific modifications such as bilingual labeling, SI unit requirements, updated climatic conditions, and substitution of some international references with Canadian equivalents. The core technical requirements for safety and essential performance are identical to the IEC base document.
Q: Is this standard mandatory for all radiotherapy simulators sold in Canada?
A: Yes, it is a recognized standard under Health Canada’s mandatory standards list (Medical Devices Regulations, Schedule 1, Class II). Manufacturers must comply to obtain a Medical Device Licence.
Q: What is the relationship between this standard and CAN CSA C22.2 No. 60601-1?
A: This particular standard is a “particular” standard that supplements the “general” standard CAN CSA C22.2 No. 60601-1. It addresses specific hazards and performance criteria for radiotherapy simulators; compliance with the general standard is also required.
Q: When will this standard be updated or replaced?
A: CSA typically revises standards every 5–7 years. As of 2026, the current edition is 2018. Manufacturers should monitor CSA’s updates for the next edition, which may adopt the upcoming IEC 60601-2-29 Ed. 4 with Canadian deviations.

Article prepared for reference and educational purposes. Always refer to the latest official CAN CSA C22.2 No. 60601-2-29-10 document for exact legal requirements. © 2026 Technical Standards Review.

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *